Incyte (INCY) Receivables (2009 - 2026)
Incyte's Receivables was $1.24 billion in Q3 2026, up 38.1% from $895.89 million a year earlier and up 9.9% from the prior quarter.
Powered by 
Analysis
Incyte (INCY) Receivables (2009 - 2026) Analysis & Trends
At the end of FY2025, Receivables at Incyte came in at $1.02 billion, up 20.1% from FY2024.
- Receivables has now increased for 12 consecutive years, with a five-year compound annual growth rate of 16.3% (FY2020 to FY2025).
- In earlier years, Receivables was $853.15 million in FY2024 (+14.7%), $743.56 million in FY2023 (+15.3%), $644.88 million in FY2022 (+4.6%) and $616.3 million in FY2021 (+27.9%).
- The Q3 2026 figure marks the highest quarterly Receivables in data going back to Q4 2010.
- Compared with a year earlier, Receivables has increased for 13 straight quarters, with growth averaging 22.1% over the last eight quarters.
- The best year-over-year quarter for Receivables over five years was Q2 2022 (growth of 55.9%); the worst was Q2 2023 (a decline of 6.6%).
- Per Business Quant data, INCY's Receivables in the three quarters before Q3 2026 was $1.13 billion (Q2 2026), $1.05 billion (Q1 2026) and $1.02 billion (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 25.23 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 18.99 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 13.51 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 12.74 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 16.16 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 10.35 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 5.01 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 14.19 Bn |
| 10 | Incyte | 245.42 Mn | -15.74 Bn | 1.45 Bn | 1.24 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.24 Bn |
| Jun 30, 2026 | 1.13 Bn |
| Mar 31, 2026 | 1.05 Bn |
| Dec 31, 2025 | 1.02 Bn |
| Sep 30, 2025 | 895.89 Mn |
| Jun 30, 2025 | 842.89 Mn |
| Mar 31, 2025 | 823.13 Mn |
| Dec 31, 2024 | 853.15 Mn |
| Sep 30, 2024 | 758.45 Mn |
| Jun 30, 2024 | 739.05 Mn |
| Mar 31, 2024 | 745.53 Mn |
| Dec 31, 2023 | 743.56 Mn |
| Sep 30, 2023 | 657.26 Mn |
| Jun 30, 2023 | 637.99 Mn |
| Mar 31, 2023 | 623.79 Mn |
| Dec 31, 2022 | 644.88 Mn |
| Sep 30, 2022 | 618.19 Mn |
| Jun 30, 2022 | 682.97 Mn |
| Mar 31, 2022 | 562.34 Mn |
| Dec 31, 2021 | 616.30 Mn |
API Access
Incyte Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=receivables&ticker=INCY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "receivables", "ticker": "INCY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=receivables&ticker=INCY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();